doi:10.1016/j.jaip.2018.11.040Anna VolermanMadeleine ToupsAshley HullMargaret DenninTae Yeon KimStacy IgnoffoLisa K. SharpValerie G. PressElsevier
The use of ICS and formoterol as both controller and quick relief therapy has been termed single maintenance and reliever therapy (SMART). This strategy is recommended in international asthma guidelines, but currently, there are no ICS-LABA combination inhalers that are approved for SMART in the ...